Cited by 1,558SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Spike mutation D614G alters SARS-CoV-2 fitness

Open access

Plante, Jessica A., Liu, Yang, Liu, Jianying, Xia, Hongjie, Johnson, Bryan A., Lokugamage, Kumari G., Zhang, Xianwen, Muruato, Antonio E., Zou, Jing, Fontes-Garfias, Camila R., Mirchandani, Divya, Scharton, Dionna, Bilello, John P., Ku, Zhiqiang, An, Zhiqiang, Kalveram, Birte, Freiberg, Alexander N., Menachery, Vineet D., Xie, Xuping, Plante, Kenneth S., Weaver, Scott C., Shi, Pei-Yong·2021·Nature

DOI 10.1038/s41586-020-2895-3PMC PMC8158177

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein substitution D614G became dominant during the coronavirus disease 2019 (COVID-19) pandemic 1,2. However, the effect of this variant on viral spread and vaccine efficacy remains to be defined. Here we engineered the spike D614G substitution in the USA-WA1/2020 SARS-CoV-2 strain, and found that it enhances viral replication in human lung epithelial cells and primary human airway tissues by increasing the infectivity and stability of virions. Hamsters infected with SARS-CoV-2 expressing spike(D614G) (G614 virus) produced higher infectious titres in nasal washes and the trachea, but not in the lungs, supporting clinical evidence showing that the mutation enhances viral loads in the upper respiratory tract of COVID-19 patients and may increase transmission. Sera from hamsters infected with D614 virus exhibit modestly higher neutralization titres against G614 virus than against D614 virus, suggesting that the mutation is unlikely to reduce the ability of vaccines in clinical trials to protect against COVID-19, and that therapeutic antibodies should be tested against the circulating G614 virus. Together with clinical findings, our work underscores the importance of this variant in viral spread and its implications for vaccine efficacy and antibody therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2895-3

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237
The New Statistics: Why and How
Cumming, G. (2014) · Psychological Science · doi:10.1177/0956797613504966 · Cited by 3,200
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569
Self-citation
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Hou, Y. J., Okuda, K., Edwards, C. E., Martinez, D. R., Asakura, T., Dinnon, K. H., Kato, T., Lee, R. E., Yount, B. L., Mascenik, T. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.042 · Cited by 1,488

Show all 37 references

Research works printed but not linked: 1

Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589–593 (2020). · DOI · Paper page

Sorted by citations

Items 301–400 of 1,008

Understanding mutation hotspots for the SARS-CoV-2 spike protein using Shannon Entropy and K-means clustering
Mullick, B., Magar, R., Jhunjhunwala, A., & Farimani, A. B. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104915 · Cited by 49
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
Hwang, W., Lei, W., Katritsis, N. M., MacMahon, M., Chapman, K. L., & Han, N. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.004 · Cited by 51
Mechanisms of Lung Injury Induced by SARS-CoV-2 Infection
Upadhya, S. W., Rehman, J., Malik, A. B., & Chen, S. (2021) · Physiology · doi:10.1152/physiol.00033.2021 · Cited by 54
SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epitheliumPreprint
Lamers, M. M., Mykytyn, A. Z., Breugem, T. I., Gröen, N., Knoops, K., Schipper, D., van Acker, R., van den Doel, P. B., Bestebroer, T. M., Koopman, C. D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.19.476898 · Cited by 47
dsmCRISPR: Dual synthetic mismatches CRISPR/Cas12a-based detection of SARS-CoV-2 D614G mutation
Huang, X., Fuming, Z., Zhu, K., Lin, W., & Ma, W. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198530 · Cited by 48
The twin-beginnings of COVID-19 in Asia and Europe—one prevails quickly
Ruan, Y., Wen, H., Hou, M., He, Z., Lu, X., Xue, Y., He, X., Zhang, Y., & Wu, C. (2021) · National Science Review · doi:10.1093/nsr/nwab223 · Cited by 46
Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations
Helms, L., Marchiano, S., Stanaway, I. B., Hsiang, T.-Y., Juliar, B. A., Saini, S., Zhao, Y. T., Khanna, A., Menon, R., Alakwaa, F., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.154882 · Cited by 47
Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations
Jacob, J. J., Vasudevan, K., Pragasam, A. K., Gunasekaran, K., Veeraraghavan, B., & Mutreja, A. (2021) · mBio · doi:10.1128/mbio.01188-21 · Cited by 48
Case report: change of dominant strain during dual SARS-CoV-2 infection
Samoilov, A. E., Kaptelova, V. V., Bukharina, A. Y., Shipulina, O. Y., Korneenko, E. V., Saenko, S., Lukyanov, A. V., Гришаева, А. А., Плоскирева, А. А., Speranskaya, A. S., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06664-w · Cited by 45
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
Sánchez‐Zuno, G. A., Matuz-Flores, M. G., González-Estévez, G., Nicoletti, F., Turrubiates‐Hernández, F. J., Mangano, K., & Muñóz-Valle, J. F. (2021) · International Journal of Immunopathology and Pharmacology · doi:10.1177/20587384211050199 · Cited by 48
Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through Omicron
Teng, I., Nazzari, A. F., Choe, M., Liu, T. W. B., de Souza, M. O., Petrova, Y. I., Tsybovsky, Y., Wang, S., Zhang, B., Artamonov, M. V., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268767 · Cited by 46
Genetic Characteristics and Phylogeny of 969-bp S Gene Sequence of SARS-CoV-2 from Hawaii Reveals the Worldwide Emerging P681H MutationPreprint
Maison, D. P., Ching, L. L., Shikuma, C. M., & Nerurkar, V. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.06.425497 · Cited by 47
Immunity to SARS-CoV-2: Lessons Learned
FERGIE, J. E., & Srivastava, A. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.654165 · Cited by 46
The Genetic Variant of SARS-CoV-2: Would it matter for Controlling the Devastating Pandemic?
Guo, S., Liu, K., & Zheng, J. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59137 · Cited by 46
SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity
Sasaki, M., Toba, S., Itakura, Y., Chambaro, H. M., Kishimoto, M., Tabata, K., Intaruck, K., Uemura, K., Sanaki, T., Sato, A., et al. (2021) · mBio · doi:10.1128/mbio.01415-21 · Cited by 46
Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19
Yan, F., Li, E., Wang, T., Li, Y., Liu, J., Wang, W., Qin, T., Su, R., Pei, H., Wang, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.821664 · Cited by 44
Self-citation
The (Re-)Emergence and Spread of Viral Zoonotic Disease: A Perfect Storm of Human Ingenuity and Stupidity
Marie, V., & Gordon, M. L. (2023) · Viruses · doi:10.3390/v15081638 · Cited by 49
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2
Stewart-Jones, G., Elbashir, S. M., Wu, K., Lee, D., Renzi, I., Ying, B., Koch, M., Sein, C. E., Choi, A., Whitener, B. M., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adf4100 · Cited by 55
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
Ying, B., Darling, T. L., Desai, P., Liang, C.-Y., Dmitriev, I. P., Soudani, N., Bricker, T. L., Kashentseva, E. A., Harastani, H., Raju, S., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01743-x · Cited by 49
Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein
Yao, Z., Zhang, L., Duan, Y., Tang, X., & Lü, J. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106121 · Cited by 49
CRISPR/Cas9-Based Lateral Flow and Fluorescence Diagnostics
Osborn, M. J., Bhardwaj, A., Bingea, S. P., Knipping, F., Feser, C. J., Lees, C. J., Collins, D. P., Steer, C. J., Blazar, B. R., & Tolar, J. (2021) · Bioengineering · doi:10.3390/bioengineering8020023 · Cited by 47
Mutations in the B.1.1.7 SARS-CoV-2 Spike Protein Reduce Receptor-Binding Affinity and Induce a Flexible Link to the Fusion Peptide
Socher, E., Conrad, M., Heger, L., Paulsen, F. P., Sticht, H., Zunke, F., & Arnold, P. (2021) · Biomedicines · doi:10.3390/biomedicines9050525 · Cited by 42
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease
Kreutzberger, A. J. B., Sanyal, A., Ojha, R., Pyle, J. D., Vapalahti, O., Balistreri, G., & Kirchhausen, T. L. (2021) · Journal of Virology · doi:10.1128/jvi.00975-21 · Cited by 44
The Development of SARS-CoV-2 Variants: The Gene Makes the Disease
Pérez-Gómez, R. (2021) · Journal of Developmental Biology · doi:10.3390/jdb9040058 · Cited by 47
Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants
Yang, Z. L., Zhang, S., Tang, Y., Zhang, S., Xu, D.-Q., Yue, S., & Liu, Q. (2022) · Aging and Disease · doi:10.14336/ad.2021.1210 · Cited by 46
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Hoteit, R., & Yassine, H. M. (2022) · Vaccines · doi:10.3390/vaccines10060919 · Cited by 47
The Impact of D614G Mutation of SARS-COV-2 on the Efficacy of Anti-viral Drugs: A Comparative Molecular Docking and Molecular Dynamics Study
Poustforoosh, A., Hashemipour, H., Tüzün, B., Azadpour, M., Faramarz, S., Pardakhty, A., Mehrabani, M., & Nematollahi, M. H. (2022) · Current Microbiology · doi:10.1007/s00284-022-02921-6 · Cited by 45
Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model
Alsaidi, S., Cornejal, N., Mahoney, O., Melo, C., Verma, N., Bonnaire, T., Chang, T. L.-Y., O’Keefe, B. R., Sailer, J., Zydowsky, T. M., et al. (2021) · Marine Drugs · doi:10.3390/md19080418 · Cited by 46
Predicting Adhesive Free Energies of Polymer–Surface Interactions with Machine Learning
Shi, J., Quevillon, M. J., Valença, P. H. A., & Whitmer, J. K. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c08891 · Cited by 45
Multiple expansions of globally uncommon SARS-CoV-2 lineages in Nigeria
Ozer, E. A., Simons, L. M., Adewumi, M. O., Fowotade, A., Omoruyi, E. C., Adeniji, J. A., Olayinka, O. A., Dean, T. J., Zayas, J. P., Bhimalli, P. P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28317-5 · Cited by 48
The impact of Spike mutations on SARS-CoV-2 neutralizationPreprint
Rees-Spear, C., Muir, L., Griffith, S. A., Heaney, J., Aldon, Y., Snitselaar, J. L., Pataillot-Meakin, T., Graham, C., Seow, J., Lee, N., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.15.426849 · Cited by 45
Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan
Umair, M., Ikram, A., Salman, M., Khurshid, A., Alam, M., Badar, N., Suleman, R., Tahir, F., Sharif, S., Montgomery, J. M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248371 · Cited by 42
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease
van der Lubbe, J. E. M., Huber, S. K. R., Vijayan, A., Dekking, L., van Huizen, E., Vreugdenhil, J., Choi, Y., Baert, M. R. M., Boer, K. F.-D., Gil, A. I., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00301-y · Cited by 44
Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents
Ma, C., Chen, X., Mei, F., Xiong, Q., Liu, Q., Dong, L., Liu, C., Zou, W., Zhan, F., Hu, B., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2031311 · Cited by 44
Self-citation
A Review: Understanding Molecular Mechanisms of Antibody-Dependent Enhancement in Viral Infections
Sawant, J., Patil, A. A., & Kurle, S. N. (2023) · Vaccines · doi:10.3390/vaccines11071240 · Cited by 44
A simple reverse genetics method to generate recombinant coronaviruses
Mélade, J., Piorkowski, G., Touret, F., Fourié, T., Driouich, J., Cochin, M., Bouzidi, H. S., Coutard, B., Nougaırède, A., & de Lamballerie, X. N. (2022) · EMBO Reports · doi:10.15252/embr.202153820 · Cited by 44
Development of colorimetric sensors based on gold nanoparticles for SARS-CoV-2 RdRp, E and S genes detection
Rodríguez-Díaz, C., Lafuente‐Gómez, N., Coutinho, C., Pardo, D., Iniesta, H. A., López‐Valls, M., Coloma, R., Milán-Rois, P., Domenech, M., Abreu, M., et al. (2022) · Talanta · doi:10.1016/j.talanta.2022.123393 · Cited by 44
The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
Zou, J., Xie, X., Fontes-Garfias, C. R., Swanson, K. A., Kanevsky, I., Tompkins, K. R., Cutler, M. W., Cooper, D., Dormitzer, P. R., & Shi, P. (2021) · npj Vaccines · doi:10.1038/s41541-021-00313-8 · Cited by 42
Self-citation
COVID-19 in Asia: Transmission factors, re-opening policies, and vaccination simulation
Baniasad, M., Mofrad, M. G., Bahmanabadi, B., & Jamshidi, S. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111657 · Cited by 44
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage
Cheng, Y. W., Chao, T., Li, C., Wang, S.-H., Kao, H., Tsai, Y., Wang, H., Hsieh, C.-L., Lin, Y.-Y., Chen, P., et al. (2021) · mBio · doi:10.1128/mbio.00587-21 · Cited by 41
Spread of Mink SARS-CoV-2 Variants in Humans: A Model of Sarbecovirus Interspecies Evolution
Devaux, C. A., Pinault, L., Delerce, J., Raoult, D., Levasseur, A., & Frutos, R. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.675528 · Cited by 44
Role of mutational reversions and fitness restoration in Zika virus spread to the Americas
Liu, J., Liu, Y., Shan, C., Nunes, B. T. D., Yun, R., Haller, S. L., Rafael, G. H., Azar, S. R., Andersen, C. R., Plante, K. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20747-3 · Cited by 43
Self-citation
Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein
Shi, Y., Zeida, A., Edwards, C. E., Mallory, M. L., Sastre, S., Machado, M. R., Pickles, R. J., Fu, L. L., Liu, K., Yang, J. H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2120419119 · Cited by 43
Superspreading in the emergence of COVID-19 variants
Gómez‐Carballa, A., Pardo‐Seco, J., Bello, X., Martinón‐Torres, F., & Salas, A. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.09.003 · Cited by 42
Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H
Zeng, C., Evans, J. P., Faraone, J. N., Qu, P., Zheng, Y.-M., Saif, L. J., Oltz, E. M., Lozanski, G., Gumina, R. J., & Liu, S. (2021) · mBio · doi:10.1128/mbio.02510-21 · Cited by 41
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates
Schrörs, B., Riesgo-Ferreiro, P., Sorn, P., Gudimella, R., Bukur, T., Rösler, T., Löwer, M., & Şahin, U. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249254 · Cited by 41
Evolution of the SARS-CoV-2 genome and emergence of variants of concern
Safari, I., & Elahi, E. (2021) · Archives of Virology · doi:10.1007/s00705-021-05295-5 · Cited by 41
Cov-MS: A Community-Based Template Assay for Mass-Spectrometry-Based Protein Detection in SARS-CoV-2 Patients
Puyvelde, B. V., Uytfanghe, K. V., Tytgat, O., Oudenhove, L. V., Gabriels, R., Bouwmeester, R., Daled, S., Bossche, T. V. D., Ramasamy, P., Verhelst, S., et al. (2021) · JACS Au · doi:10.1021/jacsau.1c00048 · Cited by 40
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera
Rathnasinghe, R., Jangra, S., Ye, C., Čupić, A., Singh, G., Martínez‐Romero, C., Mulder, L. C. F., Kehrer, T., Yildiz, S., Choi, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30763-0 · Cited by 42
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
Lee, K. S., Wong, T. Y., Russ, B. P., Horspool, A. M., Miller, O. A., Rader, N. A., Givi, J. P., Winters, M. T., Wong, Z. Y., Cyphert, H. A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273430 · Cited by 42
Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency
Alaofi, A. L., & Shahid, M. (2021) · Biomolecules · doi:10.3390/biom11091273 · Cited by 43
Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage
Shiliaev, N., Lukash, T., Palchevska, O., Crossman, D. K., Green, T. J., Crowley, M. R., Frolova, E. I., & Frolov, I. V. (2021) · Journal of Virology · doi:10.1128/jvi.01357-21 · Cited by 41
Carbon Nanotube Mask Filters and Their Hydrophobic Barrier and Hyperthermic Antiviral Effects on SARS-CoV-2
Lee, S., Nam, J., Han, J., Zhang, Q., Kauppinen, E. I., & Jeon, I. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c01386 · Cited by 41
Cross-Species Tropism and Antigenic Landscapes of Circulating SARS-CoV-2 Variants
Zhang, Y., Wei, M., Wu, Y., Wang, J., Hong, Y., Huang, Y., Yuan, L., Ma, J., Wang, K., Wang, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2022.110558 · Cited by 40
Self-citation
Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan
Hirotsu, Y., & Omata, M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009619 · Cited by 40
SARS-CoV-2 variants: biology, pathogenicity, immunity and control
Uraki, R., Korber, B., Diamond, M., & Kawaoka, Y. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01255-x · Cited by 50
ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner
Isobe, A., Arai, Y., Kuroda, D., Okumura, N., Ono, T., Ushiba, S., Nakakita, S., Daidoji, T., Suzuki, Y., Nakaya, T., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04170-6 · Cited by 40
Functional alterations caused by mutations reflect evolutionary trends of SARS-CoV-2
Cheng, L., Han, X., Zhu, Z., Qi, C., Wang, P., & Zhang, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab042 · Cited by 39
Self-citation
Molecular Epidemiology Surveillance of SARS-CoV-2: Mutations and Genetic Diversity One Year after Emerging
Flores-Alanis, A., Cruz‐Rangel, A., Rodríguez‐Gómez, F., González, J., Torres-Guerrero, C. A., Delgado, G., Cravioto, A., & Morales-Espinosa, R. (2021) · Pathogens · doi:10.3390/pathogens10020184 · Cited by 40
Impact of mutations in SARS-COV-2 spike on viral infectivity and antigenicity
Zhou, W., Xu, C., Wang, P., Anashkina, A. A., & Jiang, Q. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab375 · Cited by 42
Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein
Tan, Z. W., Tee, W.-V., Samsudin, F., Guarnera, E., Bond, P. J., & Berezovsky, I. N. (2022) · Structure · doi:10.1016/j.str.2021.12.011 · Cited by 38
The fatty acid site is coupled to functional motifs in the SARS-CoV-2 spike protein and modulates spike allosteric behaviour
Oliveira, A. S. F., Shoemark, D. K., Ibarra, A. Á., Davidson, A. D., Berger, I., Schaffitzel, C., & Mulholland, A. J. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.12.011 · Cited by 37
Systematic benchmarking of nanopore Q20+ kit in SARS-CoV-2 whole genome sequencing
Luo, J., Meng, Z., Xu, X., Wang, L., Zhao, K., Zhu, X., Qiao, Q., Ge, Y., Mao, L., & Cui, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.973367 · Cited by 39
Emergence and Evolution of a Prevalent New SARS-CoV-2 Variant in the United StatesPreprint
Pater, A. A., Bosmeny, M. S., Barkau, C. L., Ovington, K. N., Chilamkurthy, R., Parasrampuria, M., Eddington, S. B., Yinusa, A. O., White, A. A., Metz, P. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.11.426287 · Cited by 37
S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis
Ye, F., Lin, X., Chen, Z., Yang, F., Lin, S., Yang, J., Chen, H., Sun, H., Wang, L., Wen, A., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00756-4 · Cited by 37
Self-citation
Systems analysis shows that thermodynamic physiological and pharmacological fundamentals drive COVID‐19 and response to treatment
Head, R. J., Lumbers, E. R., Jarrott, B., Tretter, F., Smith, G., Pringle, K. G., Islam, S., & Martin, J. H. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.922 · Cited by 36
Variant-driven early warning via unsupervised machine learning analysis of spike protein mutations for COVID-19
de Hoffer, A., Vatani, S., Cot, C., Cacciapaglia, G., Chiusano, M. L., Cimarelli, A., Conventi, F., Giannini, A., Hohenegger, S., & Francesco Sannino, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-12442-8 · Cited by 39
A comprehensive review on Covid-19 Omicron (B.1.1.529) variant
Manjunath, R., Gaonkar, S. L., Saleh, E. A. M., & Husain, K. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.103372 · Cited by 42
D614G mutation eventuates in all VOI and VOC in SARS-CoV-2: Is it part of the positive selection pioneered by Darwin?
Chakraborty, C., Saha, A., Sharma, A. R., Bhattacharya, M., Lee, S., & Agoramoorthy, G. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.07.011 · Cited by 40
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure
Rando, H. M., MacLean, A. L., Lee, A. J., Lordan, R., Ray, S., Bansal, V., Skelly, A. N., Sell, E., Dziak, J. J., Shinholster, L., et al. (2021) · mSystems · doi:10.1128/msystems.00095-21 · Cited by 42
Coincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in Nigeria
Ozer, E. A., Simons, L. M., Adewumi, O. M., Fowotade, A. A., Omoruyi, E. C., Adeniji, J. A., Dean, T. J., Zayas, J., Bhimalli, P. P., Ash, M. K., et al. (2021) · doi:10.1101/2021.04.09.21255206 · Cited by 34
Functional and druggability analysis of the SARS-CoV-2 proteome
Cavasotto, C. N., Sánchez‐Lamas, M., & Maggini, J. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173705 · Cited by 38
Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene
Pyke, A. T., Nair, N., van den Hurk, A. F., Burtonclay, P., Nguyen, S. H., Barcelon, J., Kistler, C., Schlebusch, S., McMahon, J., & Moore, F. (2021) · Viruses · doi:10.3390/v13061087 · Cited by 36
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
Tulimilli, S. V., Dallavalasa, S., Basavaraju, C. G., Rao, V. K., Chikkahonnaiah, P., Madhunapantula, S. V., & Veeranna, R. P. (2022) · Vaccines · doi:10.3390/vaccines10101751 · Cited by 39
The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection
Maiuolo, J., Mollace, R., Gliozzi, M., Musolino, V., Carresi, C., Paone, S., Scicchitano, M., Macrì, R., Nucera, S., Bosco, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239309 · Cited by 38
SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus
Havranek, K. E., Jimenez, A. R., Acciani, M. D., Mendoza, M. L., Ballista, J. M. R., Diaz, D., & Brindley, M. A. (2020) · Viruses · doi:10.3390/v12121465 · Cited by 37
Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19
Sharma, A., Kontodimas, K., & Bosmann, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.648005 · Cited by 39
Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights
Nagy‐Szakal, D., Couto-Rodriguez, M., Wells, H., Barrows, J., Debieu, M., Butcher, K. D., Chen, S., Berki, A., Hager, C., Boorstein, R. J., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00197-21 · Cited by 36
The Rapid Assessment of Aggregated Wastewater Samples for Genomic Surveillance of SARS-CoV-2 on a City-Wide Scale
Fuqua, J. L., Rouchka, E. C., Waigel, S., Sokoloski, K. J., Chung, D., Zacharias, W., Zhang, M., Chariker, J. H., Talley, D., Santisteban, I. C., et al. (2021) · Pathogens · doi:10.3390/pathogens10101271 · Cited by 37
Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity
Alefishat, E. A., Jelinek, H. F., Mousa, M., Tay, G. K., & AlSafar, H. S. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.01.007 · Cited by 39
Rampant C-to-U deamination accounts for the intrinsically high mutation rate in SARS-CoV-2 spike gene
Liu, X., Liu, X., Zhou, J., Dong, Y., Jiang, W., & Jiang, W. (2022) · RNA · doi:10.1261/rna.079160.122 · Cited by 37
Risk assessment for long- and short-range airborne transmission of SARS-CoV-2, indoors and outdoors
Poydenot, F., Abdourahamane, I., Caplain, E., Der, S., Haiech, J., Jallon, A., Khoutami, I., Loucif, A., Marinov, E., & Andreotti, B. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac223 · Cited by 42
Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020–2022
Puenpa, J., Rattanakomol, P., Saengdao, N., Chansaenroj, J., Yorsaeng, R., Suwannakarn, K., Thanasitthichai, S., Vongpunsawad, S., & Poovorawan, Y. (2023) · Archives of Virology · doi:10.1007/s00705-022-05666-6 · Cited by 37
Antigenic evolution of SARS coronavirus 2
Mykytyn, A. Z., Fouchier, R. A. M., & Haagmans, B. L. (2023) · Current Opinion in Virology · doi:10.1016/j.coviro.2023.101349 · Cited by 36
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variantPreprint
Edara, V. V., Norwood, C., Floyd, K. A., Lai, L., Davis-Gardner, M. E., Hudson, W. H., Mantus, G. E., Nyhoff, L. E., Adelman, M. W., Fineman, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.20.432046 · Cited by 37
Ongoing Positive Selection Drives the Evolution of SARS-CoV-2 Genomes
Hou, Y., Zhao, S., Liu, Q., Zhang, X., Sha, T., Su, Y., Zhao, W., Bào, Y., Xue, Y., & Chen, H. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.05.009 · Cited by 35
Self-citation
Wastewater pandemic preparedness: Toward an end-to-end pathogen monitoring program
Clark, J. R., Terwilliger, A. L., Avadhanula, V., Tisza, M. J., Cormier, J., Cregeen, S. J., Ross, M. C., Hoffman, K. L., Troisi, C. L., Hanson, B., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1137881 · Cited by 36
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope
Liu, Z., Xu, W., Chen, Z., Fu, W., Zhan, W., Gao, Y., Zhou, J., Zhou, Y., Wu, J., Wang, Q., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00871-6 · Cited by 38
Self-citation
Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects
Lusvarghi, S., Wang, W., Herrup, R., Neerukonda, S. N., Vassell, R. A., Bentley, L., Eakin, A. E., Erlandson, K. J., & Weiss, C. D. (2021) · Journal of Virology · doi:10.1128/jvi.01110-21 · Cited by 33
TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
Khan, H., Winstone, H., Jiménez-Guardeño, J. M., Graham, C., Doores, K. J., Goujon, C., Matthews, D. A., Davidson, A. D., Rihn, S. J., Palmarini, M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009820 · Cited by 34
Infections with the SARS-CoV-2 Delta variant exhibit fourfold increased viral loads in the upper airways compared to Alpha or non-variants of concern
von Wintersdorff, C. J. H., Dingemans, J., van Alphen, L. B., Wolffs, P. F. G., van der Veer, B. M. J. W., Hoebe, C. J. P. A., & Savelkoul, P. H. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-18279-5 · Cited by 45
Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk with altered NTD dynamics
Braet, S. M., Buckley, T. S., Venkatakrishnan, V., Dam, K.-M. A., Björkman, P. J., & Anand, G. S. (2023) · eLife · doi:10.7554/elife.82584 · Cited by 36
The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscapePreprint
Martin, D. P., Weaver, S., Tegally, H., San, E. J., Shank, S. D., Wilkinson, E., Lucaci, A. G., Giandhari, J., Naidoo, S., Pillay, Y., et al. (2021) · PubMed · doi:10.34944/dspace/7022 · Cited by 49
Self-citation
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
Chen, R. E., Gorman, M. J., Zhu, D. Y., Carreño, J. M., Yuan, D., VanBlargan, L. A., Burdess, S., Lauffenburger, D. A., Kim, W., Turner, J. S., et al. (2021) · Med · doi:10.1016/j.medj.2021.11.004 · Cited by 37
Adaptive Evolution of the Spike Protein in Coronaviruses
Tang, X., Qian, Z., Lu, X., & Lü, J. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad089 · Cited by 36
Wastewater surveillance of SARS-CoV-2 genomic populations on a country-wide scale through targeted sequencing
Cancela, F., Ramos, N., Smyth, D., Etchebehere, C., Berois, M., Rodríguez, J., Rufo, C., Alemán, A., Borzacconi, L., López, J., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284483 · Cited by 29
Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil
Franceschi, V. B., Caldana, G. D., Mayer, A. D. M., Cybis, G. B., Neves, C. A. M., Ferrareze, P. A. G., Demoliner, M., de Almeida, P. R., Gularte, J. S., Hansen, A. W., et al. (2021) · BMC Genomics · doi:10.1186/s12864-021-07708-w · Cited by 34
Recent Advances in Two-Dimensional Transition Metal Dichalcogenide Nanocomposites Biosensors for Virus Detection before and during COVID-19 Outbreak
Lam, C. Y. K., Zhang, Q., Yin, B., Huang, Y., Wang, H., Yang, M., & Wong, S. H. D. (2021) · Journal of Composites Science · doi:10.3390/jcs5070190 · Cited by 35
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
Prates-Syed, W. A., Chaves, L. C. S., Crema, K. P., Vuitika, L., Lira, A. A. D. L., Côrtes, N., Kersten, V., Guimarães, F. E. G., Sadraeian, M., da Silva, F. L. B., et al. (2021) · Vaccines · doi:10.3390/vaccines9121409 · Cited by 36
Role of the Microbiome in the Pathogenesis of COVID-19
De, R., & Dutta, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.736397 · Cited by 35

Authors: Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., Mirchandani, D., Scharton, D., Bilello, J. P., Ku, Z., An, Z., Kalveram, B., Freiberg, A. N., Menachery, V. D., Xie, X., Plante, K. S., Weaver, S. C., & Shi, P.-Y.
Affiliations: The University of Texas Medical Branch at Galveston (US)
Gilead Sciences (United States) (US)
Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (US)
Corresponding author: Xie, Xuping
Plante, Kenneth S.
Weaver, Scott C.
Shi, Pei-Yong
ORCID: Plante, Jessica A.
Liu, Jianying
Xia, Hongjie
Johnson, Bryan A.
Zhang, Xianwen
Zou, Jing
Fontes-Garfias, Camila R.
Scharton, Dionna
Bilello, John P.
Ku, Zhiqiang
An, Zhiqiang
Freiberg, Alexander N.
Menachery, Vineet D.
Xie, Xuping
Plante, Kenneth S.
Weaver, Scott C.
Shi, Pei-Yong
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-10-26
Volume: 592
Issue: 7852
Pages: 116-121
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2895-3
PMC: PMC8158177
OpenAlex: W3093768302
Cited by: 1,558
References: 37
Citations by year: 2026: 37 · 2025: 73 · 2024: 120 · 2023: 174 · 2022: 427 · 2021: 670 · 2020: 55
FWCI: 43.60
Type: journal article
Language: en
Update notices: correction (2021-06-15)
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
PubMed Central (submittedVersion, cc-by-nc-nd)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Amon G. Carter Foundation
John S. Dunn Foundation (AI145617)
University of Texas System
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (AI134907)
National Institutes of Health (AG049042, TL1TR001440, AI145617, AI142759, UL1TR001439)
National Institute on Aging (AI142759, AG049042, R00AG049092)
National Institute of Allergy and Infectious Diseases (R43AI145617, AI142759, R24AI120942, R01AI134907, R21AI145400, U01AI151801, U19AI142759, R01AI153602, AI153602, AG049042, AI134907, AI145617, UC7AI094660)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: SARS-CoV-2, viral fitness, viral replication, upper respiratory tract infection, virus transmission, neutralizing antibodies, vaccine efficacy, hamster model, lung epithelial cells, therapeutic antibodies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Spike mutation D614G alters SARS-CoV-2 fitness

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks